SCHEMBL7987432

SCHEMBL7987432

CCc1nc2ncn(Cc3ccc(C)cc3)c2c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 1/20 0.47
BRD4 O60885 4/20 0.41
BRD2 P25440 1/20 0.40
BRD3 Q15059 1/20 0.40
BRDT Q58F21 1/20 0.40
LMNA P02545 2/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
HTT P42858 1/20 0.40
TSHR P16473 1/20 0.39
DCTPP1 Q9H773 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7989373 0.90 HPGD (0.46) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7988126 0.89 HPGD (0.49) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7984524 0.89 HPGD (0.52) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7984374 0.89 HPGD (0.43) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7975251 0.89 SMN1; SMN2 (0.60) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7988041 0.87 SMN1; SMN2 (0.47) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7973932 0.87 SMN1; SMN2 (0.53) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7984464 0.87 ABCC8 (0.50) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL7975136 0.87 HPGD (0.45) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4
SCHEMBL8059820 0.86 HPGD (0.52) HPGDSMN1; SMN2ALDH1A1KMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed